James J. Bochnowski's Insider Trades & SAST Disclosures
James J. Bochnowski's most recent trade in Jaguar Health Inc was a trade of 27,002 Convertible Promissory Note done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James J. Bochnowski.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jaguar Health Inc | James J. Bochnowski | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 27,002 | 27,002 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | James J. Bochnowski | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 27,002 | 27,002 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 23,200 | 23,200 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 76,613 | 78,876 (0%) | 0% | 0 | Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,280 | 2,263 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,280 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | James J. Bochnowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 13,133 | 73,765 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 13,133 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 96,015 | 96,015 | - | - | Restricted stock units | |
| Jaguar Health Inc | James J. Bochnowski | Director | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 03 Jun 2021 | 292 | 954,542 (6%) | 0% | 1.8 | 511 | Common Stock |
| Jaguar Health Inc | James J. Bochnowski | Director | Sale of securities on an exchange or to another person at price $ 1.74 per share. | 03 Jun 2021 | 152 | 954,390 (6%) | 0% | 1.7 | 264 | Common Stock |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 78,750 | 78,750 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 39,400 | 39,400 | - | - | Restricted stock units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges